Jeanne Freddura
Corporate Officer/Principal bei COMMUNITY REDEVELOPMENT INC.
Profil
Jeanne Freddura is currently the Senior Vice President-Finance & Development at Community Redevelopment, Inc. Her former job was as a Controller at Syntimmune, Inc. She has a graduate degree from Harvard University and an undergraduate degree from Cambridge College.
Aktive Positionen von Jeanne Freddura
| Unternehmen | Position | Beginn |
|---|---|---|
| COMMUNITY REDEVELOPMENT INC. | Corporate Officer/Principal | 02.02.2022 |
Ehemalige bekannte Positionen von Jeanne Freddura
| Unternehmen | Position | Ende |
|---|---|---|
Syntimmune, Inc.
 Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | Comptroller/Controller/Auditor | - |
Ausbildung von Jeanne Freddura
| Harvard University | Graduate Degree |
| Cambridge College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| COMMUNITY REDEVELOPMENT INC. | Finance |
| Private Unternehmen | 1 |
|---|---|
Syntimmune, Inc.
Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | Health Technology |
